Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches

Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches

In recent years, the use of immune checkpoint inhibitors (ICIs) in combination with approved or experimental vaccines has proven to be a promising approach to improve vaccine immunogenicity and efficacy. This strategy seeks to overcome the immunosuppressive mechanisms associated with the vaccine res...

Full description

Bibliographic Details
Main Authors: Alexander Batista-Duharte, Fakhri Hassouneh, Pablo Alvarez-Heredia, Alejandra Pera, Rafael Solana
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
immune checkpoint inhibitors
molecular adjuvants
vaccines
monoclonal antibodies
antisense oligonucleotides
aptamers
Online Access:https://www.mdpi.com/1999-4923/14/8/1721

Similar Items

Similar Items